Key Takeaways:
Berger Montague filed a securities fraud class action against EquipmentShare.com Inc., whose shares have fallen more than 34.5 percent from their $24.50 IPO price.
"Investors who purchased EquipmentShare securities during the Class Period may, no later than September 21, 2026, seek to be appointed as a lead plaintiff representative of the class," the Philadelphia-based law firm said in a statement.
The suit covers investors who bought EquipmentShare (NASDAQ: EQPT) shares from January 19 through June 23, 2026, including those in or traceable to the company's January 2026 initial public offering. The complaint alleges the company failed to disclose related-party transactions with entities owned or controlled by its co-founders, including in the IPO registration statement.
The truth began to emerge June 24, when Umibozu Research published a report alleging EquipmentShare had engaged in undisclosed related-party transactions that generated millions of dollars for founder-affiliated entities through its OWN program. The stock fell 6.6 percent that day, from $23.88 to $22.30, then dropped another 11.7 percent to close at $19.69. It later traded as low as $16.06, a decline of more than 34.5 percent from the $24.50 IPO price.
EquipmentShare, headquartered in Columbia, Missouri, provides equipment rental, retail, and technology-enabled fleet management services to construction customers. Its OWN program lets customers purchase equipment through the company, and the complaint alleges founder-affiliated entities profited from those transactions without disclosure. The company's T3 platform manages people, assets, and materials in real time across its rental and sales segments.
The company reported Q2 revenue of $1.45 billion, beating the FactSet consensus of $1.15 billion, and adjusted EPS of $0.18 versus an expected loss of $0.06. It guided full-year 2026 revenue to $5.254 billion to $5.682 billion. August SEC filings show insiders sold shares worth $26.7 million and $18.7 million.
The stock traded at $17.50 on Aug. 31, down 1.19 percent, with a five-day decline of 6.58 percent. Analysts remain bullish — Truist maintains a Buy rating with a $35 price target, while UBS holds Neutral at $22. The consensus among 11 analysts is Buy with an average target of $33.20, implying about 87 percent upside.
The lawsuit adds legal and reputational risk to a newly public company still establishing its post-IPO valuation. Investors will watch the lead plaintiff appointment process, with the deadline to seek that role set for September 21, 2026.
This article is for informational purposes only and does not constitute investment advice.
